The global pharma industry experienced a 2% drop in new job postings in Q2 2024 compared with the previous quarter, with the highest share accounted for by Biocon with 10,170 job postings according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharma: Hiring Trends & Signals Q2 2024 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Management Occupations jobs accounted for a 20% share of the global pharma industry’s new job postings in Q2 2024, up 5% over the prior quarter.
Management Occupations drive pharma industry hiring activity
Management Occupations, with a share of 20%, was the occupation with the greatest hiring activity in the global pharma industry in Q2 2024, ahead of Life, Physical, and Social Science Occupations with a 7% share of job postings.
The other prominent roles include Healthcare Practitioners and Technical Occupations with a 7% share in Q2 2024, Computer and Mathematical Occupations with a 3% share and Business and Financial Operations Occupations with a 4% share of new job postings.
Top five companies in pharma industry accounted for 31% of hiring activity
The top five companies, in terms of number of new job postings tracked by GlobalData, accounted for a combined 31% share of the overall hiring activity in the global pharma industry in Q2 2024.
Biocon posted 10,170 jobs in Q2 2024 and registered a growth of 20% over the previous quarter, followed by Eurofins Scientific with 7,531 jobs and a 2% growth. AstraZeneca with 4,980 jobs and AbbVie with 4,192 jobs, recorded a 1% decline and a 56% rise, respectively, while CSL recorded a 50% rise with 3,969 job postings during Q2 2024.
Hiring activity was driven by North America with a 43% share of total new job postings, Q2 2024
North America held the leading share of the new job postings in the global pharma industry with a 43% share, 0% remained flat over Q1 2024. Asia-Pacific stood next with 27%, registering a 1% decline over the previous quarter.
Europe with a 25% share marked a 4% drop over Q1 2024. The South & Central America and Middle East & Africa accounted for shares of 8% and 4% respectively.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q2 2024, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.